Monopril and Zelnorm drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Monopril (fosinopril sodium) and Zelnorm (tegaserod maleate). Common drug interactions include cardiomyopathy among females and diabetes mellitus among males.

The phase IV clinical study analyzes what interactions people have when they take Monopril and Zelnorm. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Monopril?

Monopril has active ingredients of fosinopril sodium. It is often used in high blood pressure. eHealthMe is studying from 5,910 Monopril users. Check the latest studies of Monopril.

What is Zelnorm?

Zelnorm has active ingredients of tegaserod maleate. eHealthMe is studying from 7,261 Zelnorm users. Check the latest studies of Zelnorm.



On Jul, 22, 2026

22 people who take Monopril and Zelnorm together, and have interactions are studied.

Monopril and Zelnorm drug interactions.

What are the common drug interactions of Monopril and Zelnorm, by gender? *:

female:

  1. Cardiomyopathy (weakening of the heart muscle)
  2. Cerebrovascular disorder (disease of brain)
  3. Chest wall pain
  4. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  5. Costovertebral angle tenderness
  6. Cystocele (a condition that occurs when the tough fibrous wall between a woman's bladder and her vagina is torn by childbirth)
  7. Death
  8. Dyspepsia (indigestion)
  9. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
  10. Emotional distress

male:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Diabetes mellitus inadequate control
  3. Acute myocardial infarction (acute heart attack)
  4. Blood cholesterol increased
  5. Blood triglycerides increased
  6. Cardiac failure congestive
  7. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  8. Hyperglycaemia (high blood sugar)
  9. Irritable bowel syndrome
  10. Pancreatitis acute (sudden inflammation of pancreas)

What are the common drug interactions of Monopril and Zelnorm, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Diabetic gastroparesis (paralysis of the muscles of the stomach caused by diabetes)
  3. Diabetic nephropathy (diabetic kidney disease)
  4. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  5. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  6. Ketoacidosis (high concentrations of ketone bodies in blood)
  7. Pancreatitis (inflammation of pancreas)
  8. Vision blurred
  9. Diabetes mellitus inadequate control
  10. Pancreatitis acute (sudden inflammation of pancreas)

40-49:

  1. Pyrexia (fever)
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Sinusitis (inflammation of sinus)
  4. Tremor (trembling or shaking movements in one or more parts of your body)
  5. Vomiting
  6. Bone cancer metastatic
  7. Metastases to bone (cancer spreads to bone)
  8. Wheezing (a high-pitched whistling sound made while you breath)
  9. Cardiomegaly (increased size of heart than normal)
  10. Hepatic lesion

50-59:

  1. Abdominal distension
  2. Abdominal pain

60+:

  1. Oedema peripheral (superficial swelling)
  2. Arthralgia (joint pain)
  3. Atrioventricular block complete (heart block complete)
  4. Back injury
  5. Blood cholesterol increased
  6. Blood pressure fluctuation
  7. Blood triglycerides increased
  8. Bradycardia (abnormally slow heart action)
  9. Breast tenderness
  10. Cardiac murmur (an heart sound in valve abnormality)

What are the existing conditions these people have? *

  1. Pain: 11 people, 50.00%
  2. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 6 people, 27.27%
  3. Breast Cancer: 6 people, 27.27%
  4. Nausea And Vomiting: 5 people, 22.73%
  5. Intervertebral Disc Degeneration (spinal disc degeneration): 5 people, 22.73%
  6. Glossitis (infection of tongue with soreness): 5 people, 22.73%
  7. Dissociative Disorder: 5 people, 22.73%
  8. Depression: 4 people, 18.18%
  9. Stress And Anxiety: 3 people, 13.64%
  10. Irritable Bowel Syndrome: 3 people, 13.64%

* Approximation only. Some reports may have incomplete information.

Do you take Monopril and Zelnorm?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Monopril and Zelnorm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Monopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zelnorm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Monopril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zelnorm and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fosinopril sodium and tegaserod maleate (the active ingredients of Monopril and Zelnorm, respectively), and Monopril and Zelnorm (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: